LUCERNE Extension (Avonelle-x)

LUCERNE Extension (Avonelle-x)

LUCERNE Study (Protocol number: GR40844)

A two year multicentre, randomized, double-masked, active comparator controlled study to evaluate the efficacy and safety of Faricimab in participants with Neovascular Age-Related Macular Degeneration.

ClinicalTrials.gov Identifier: NCT03823300

Principal Investigator: Dr Balaratnasingam, Chandra

For further information about this study, you may visit Clinical Trial Registry:


Or contact the Lions Eye Institute Clinical Trials Office telephone (08) 9381 0750 or email clinicalresearch@lei.org.au

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

Request an appointment